A groundbreaking study published in Nature Communications has raised significant concerns about the impact of cannabis use on female fertility, particularly during in vitro fertilization (IVF) procedures. The research indicates that exposure to tetrahydrocannabinol (THC), the primary psychoactive compound in cannabis, may lead to chromosomal abnormalities in embryos, potentially affecting the success of IVF treatments.
Key Findings of the Study
The study, led by Cyntia Duval from the University of Toronto and the CReATe Research Program, analyzed 1,059 follicular fluid samples from women undergoing IVF between 2016 and 2023. Of these, 62 samples tested positive for THC metabolites, suggesting recent cannabis use. Notably, 73% of these women had not reported cannabis use, highlighting the importance of objective testing over self-reports.
The research revealed several concerning outcomes:
Reduced Embryo Quality: Women with THC-positive samples had a significantly lower rate of euploid embryos—those with the correct number of chromosomes—compared to controls.
Increased Chromosomal Errors: Laboratory experiments on immature egg cells exposed to THC showed a higher rate of chromosome segregation errors and abnormal spindle structures, crucial for accurate chromosome division.
Altered Gene Expression: THC exposure led to changes in the expression of genes involved in inflammation, extracellular matrix remodeling, and chromosome segregation, all vital for healthy egg development.
Implications for IVF Success
The presence of chromosomal abnormalities in embryos is a leading cause of IVF failure, implantation issues, and miscarriage. The study’s findings suggest that even low levels of THC exposure can compromise embryo viability, potentially prolonging the time to conception and reducing the likelihood of a successful pregnancy.
Expert Opinions and Recommendations
Jamie Lo, an associate professor of obstetrics and gynecology at Oregon Health & Science University, emphasized the consistency of these findings with existing knowledge about the negative effects of cannabis on reproductive health. She advises patients trying to conceive to avoid cannabis use and suggests harm reduction strategies for those who cannot abstain.
While the study provides compelling evidence, researchers caution that further investigations are needed to fully understand the long-term effects of THC on female fertility and pregnancy outcomes. Factors such as patient age and the frequency of cannabis use were not fully accounted for in this study, and these variables may influence the results.
Conclusion
As cannabis use becomes more prevalent and its legalization expands, understanding its impact on reproductive health is crucial. This study underscores the potential risks associated with cannabis use during fertility treatments and highlights the need for informed decision-making and counseling for individuals undergoing IVF.
For those considering or undergoing fertility treatments, it is advisable to discuss cannabis use with a healthcare provider to understand its potential effects and make informed choices.
YOU MAY ALSO LIKE
Fall 2025 IVF Grant Program Offers $15K Awards to Families in Need
5 Dermatologist-Approved Steps to Achieve a Smooth, Irritation-Free Shave
